Marthe Kirkesaether Brun (Marthe Kirkesæther Brun)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Ulcerative Colitis

Ejection Fraction

Top Venues

Journal of internal medicine

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Marthe Kirkesaether Brun, Kristin Hammersbøen Bjørlykke, Marte K Viken, Grethe-Elisabeth Stenvik, Rolf Anton Klaasen, Johanna Elin Gehin, David John Warren, Joseph Sexton, Øystein Sandanger, Tore K Kvien, Cato Mørk, Espen A Haavardsholm, Jørgen Jahnsen, Guro Løvik Goll, Benedicte A Lie, Nils Bolstad, Kristin Kaasen Jørgensen, Silje Watterdal Syversen
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases. Journal of internal medicine (2023)
Johanna Elin Gehin, Guro Løvik Goll, Marthe Kirkesaether Brun, Meghna Jani, Nils Bolstad, Silje Watterdal Syversen
Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (6) (2022)
Marthe Kirkesaether Brun, Guro Løvik Goll, Kristin Kaasen Jørgensen, Joseph Sexton, Johanna Elin Gehin, Øystein Sandanger, Inge Christoffer Olsen, Rolf Anton Klaasen, David John Warren, Cato Mørk, Tore K Kvien, Jørgen Jahnsen, Nils Bolstad, Espen A Haavardsholm, Silje Watterdal Syversen
Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial. Journal of internal medicine 292 (3) (2022)